Using pathway analysis, the DEGs were enriched in a total of 46 signaling pathways, including the FOXO pathway, MAPK pathway, cytokine-cytokine receptor, JAK-STAT pathway, the NF-κB pathway, TNF pathway, endometrial cancer pathway, fructose and mannose metabolism, IL-17 pathway, toll-like receptor pathway, NOD-like receptor pathway, and cAMP pathway (Figure 1B). This evidence concerns the gene IL17A and endometrial cancer.